Chest Compression Techniques for Cardiac Arrest in Newborns
(SUR1VE-2 Trial)
Trial Summary
What is the purpose of this trial?
Newborn infants who require cardiopulmonary resuscitation at birth receive chest compression using a 3-Compression to 1-Ventilation (3:1 C:V) ratio. However, the optimal chest compression technique during cardiopulmonary resuscitation is uncertain and identified as a critical gap in evidence. The International Consensus Statement advises to use the 3:1 C:V ratio based on animal studies, and states that there are no clinical trials to support this approach and called for more research. There continues to be uncertainty about the optimal chest compression technique during cardiopulmonary resuscitation. This trial will compare if in newborn infants with cardiac arrest in the delivery room does providing CC+SI (a new chest compression technique) compared to 3:1 C:V decreases the incidence of mortality at hospital discharge. This will be a multi-centre international cluster randomized trial.
Eligibility Criteria
This trial is for newborn infants who experience cardiac arrest in the delivery room and require cardiopulmonary resuscitation. The eligibility criteria are not fully listed, but typically include specific health conditions of the infant.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- 3:1 C:V (Procedure)
- CC+SI (Procedure)